An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance.

Mitra, Doyel

An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance. [electronic resource] - Molecular cancer therapeutics Aug 2009 - 2152-62 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1538-8514

10.1158/1535-7163.MCT-09-0295 doi


Animals
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--pharmacology
Breast Neoplasms--drug therapy
Cell Line, Tumor
Drug Resistance, Neoplasm
Female
Fluorescent Antibody Technique
Gene Expression Regulation, Neoplastic
Humans
Mice
NIH 3T3 Cells
Protein Isoforms--genetics
Receptor, ErbB-2--genetics
Signal Transduction
Transfection
Trastuzumab